Tag: Nursing

  • [Solved] Weekly Clinical Experience 1

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    Describe your clinical experience for this week. Must be on Geriatric Patient – Did you face any challenges, any success? If so, what were they? – Describe the assessment of a patient, detailing the signs and symptoms (S&S), assessment, plan of care, and at least 3 possible differential diagnosis wi…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Describe your clinical experience for this week.

    Must be on Geriatric Patient

    – Did you face any challenges, any success? If so, what were they?
    – Describe the assessment of a patient, detailing the signs and symptoms (S&S), assessment, plan of care, and at least 3 possible differential diagnosis with rationales.
    – Mention the health promotion intervention for this patient.
    – What did you learn from this week's clinical experience that can beneficial for you as an advanced practice nurse?
    – Support your plan of care with the current peer-reviewed research guideline.

    **Submission Instructions:**

    – Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources

    – 2 years ago

  • [Solved] disc2

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    One common dilemma faced by psychiatric nurse practitioners is determining who the “client” is. Given that children are typically brought for treatment by their parents, describe how the psychiatric nurse practitioner would respond to a child who discloses they are indulging in illicit behavior and …

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    One common dilemma faced by psychiatric nurse practitioners is determining who the “client” is. Given that children are typically brought for treatment by their parents, describe how the psychiatric nurse practitioner would respond to a child who discloses they are indulging in illicit behavior and asks you not to tell his or her parents.

    Your initial post should be at least 500 words, formatted, and cited in current APA style with support from at least 2 academic sources.

    – 2 years ago

  • [Solved] Create a reply for a discussion using APA 7 format, and scholarly references no older than 5 years.

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    **Please ensure that the Discussion includes more than 200 words with scholarly articles, and the plagiarism level must remain below 20%.** **Mounjaro vs Ozempic: A Guide to Two Endocrine Disorder Treatments** Well-established pharmacological agents have made considerable advances in treating endocr…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    **Please ensure that the Discussion includes more than 200 words with scholarly articles, and the plagiarism level must remain below 20%.**

    **Mounjaro vs Ozempic: A Guide to Two Endocrine Disorder Treatments**

    Well-established pharmacological agents have made considerable advances in treating endocrine disorders, precisely type 2 diabetes mellitus (T2DM) and obesity. Newer agents, such as Mounjaro (tirzepatide) and Ozempic (semaglutide), are well-known for their blood sugar-regulating and weight loss-promoting effects. Both agents are incretin-based therapies but have unique pharmacological profiles that affect their clinical use.

    **Similarities**

    Mounjaro and Ozempic have many similarities, including their mechanism of action and therapeutic benefits. Both agents, as incretin mimetics, act on the glucagon-like peptide-1 (GLP-1) receptor to increase insulin release, decrease glucagon secretion, and delay gastric emptying, ultimately resulting in better control of blood sugar levels. (Jastreboff et al., 2022). Furthermore, both Exenatide and Semaglutide are injected subcutaneously and have demonstrated clinically meaningful weight loss in people with T2DM and obesity (Garber, 2022). These similarities underline their potential for aiding in ameliorating blood glucose levels and the more general metabolic derangements accompanying obesity and diabetes.

    **Differences**

    While they have similarities, Mounjaro and Ozempic vary in some important ways. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, while Ozempic (semaglutide) is a specific GLP-1 receptor agonist (Frías et al., 2021). Mounjaro's extra GIP receptor activity provides better insulin secretion and potential additional weight loss benefits than Ozempic. Clinical trials have indicated that tirzepatide may significantly reduce HbA1c and body weight more than semaglutide (Jastreboff et al., 2022). Additionally, there are also differences in dosing; Ozempic is started at a lower dose (0.25 mg weekly) and titrated to a maximum of 2 mg weekly, while Mounjaro is available in a range of doses (2.5 mg to 15 mg weekly) to suit different patient needs (Garber, 2022).

    **Clinical Implications**

    Introducing Mounjaro and Ozempic is initiating a new phase in T2DM and obesity management. The improved weight loss and glycemic control with Mounjaro could translate into preferential usage in patients needing more robust metabolic agents. However, healthcare providers need to consider cost, willingness to take medication, and risk of complications such as gastrointestinal disturbance for proper therapy. More studies are necessary on these agents' long-term safety and cardiovascular impact.

    **Conclusion**

    Mounjaro and Ozempic are valuable agents in the pharmacologic management of diabetes and obesity, respectively; because these medications have different mechanisms of action and clinical effects, individualized treatment decisions are needed to provide the best possible patient results.

    **References**

    Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., & Liu, B. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. _New England Journal of Medicine, 385_(6), 503-515. https://doi.org/10.1056/NEJMoa2107519

    Garber, A. J. (2022). Incretin-based therapies in managing type 2 diabetes: Role of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists. _Diabetes Care, 45_(Suppl 1), S219-S227. https://doi.org/10.2337/dc21-S014

    Jastreboff, A. M., Kaplan, L. M., Frías, J. P., Wu, Q., Du, Y., Sturm, K., & Hompesch, M. (2022). Effects of tirzepatide on body weight in people with obesity: A phase 3 trial. _New England Journal of Medicine, 387_(3), 205-216. https://doi.org/10.1056/NEJMoa2206038

    Semaglutide vs Trizepatide. https://www.premieraestheticsva.com/post/semaglutide-vs-trizepatide

    – 2 years ago

  • [Solved] Create a reply for a discussion using APA 7 format, and scholarly references no older than 5 years.

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    **Please ensure that the Discussion includes more than 200 words with scholarly articles, and the plagiarism level must remain below 20%.** For the treatment of diabetes mellitus (DM) type 2 and obesity the pharmacology has noted significant advances in these fields. There are two new medications to…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    **Please ensure that the Discussion includes more than 200 words with scholarly articles, and the plagiarism level must remain below 20%.**

    For the treatment of diabetes mellitus (DM) type 2 and obesity the pharmacology has noted significant advances in these fields. There are two new medications to come on the endocrinology scenario that are called Mounjaro (tripeptide) and Ozempic (semaglutide) because of their efficacy in these conditions DM type 2 and obesity. Both drugs are glucagon-like peptide 1 (GLP-1) receptor agonists, which imitate the natural GLP-1 hormone that helps to control the blood sugar and appetite. Like drugs, they have detailed differences: their mechanisms of action and the variety of conditions they treat will have clinical implications for their use in endocrine disorders. An important similarity between Mounjaro and Ozempic is that they act on the GLP-1 receptor, which helps regulate insulin liberation and glucagon release in response to food intake. This is about better blood sugar control. Thus, these are highly effective in treating type 2 diabetes (Latif et al., 2021). Moreover, both drugs help in weight loss, which is a key of the managing obesity frequently associated with type 2 diabetes. Clinical investigation of these two medications have shown that they guide the substantial decreases in HbA1c (a marker of long-term blood sugar control) and body weight and, therefore, are beautiful treatment options for patients with both conditions.

    However, the principal difference with the Mounjaro and Ozempic is how they work. Mounjaro, in the manuscript, was described as a doble agonist of the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor (Zheng et al., 2024). Another hormone that regulates insulin and glucose metabolism is Mounjaro, and it has the added capacity to target both GLP-1 and GIP receptors, expanding its potential effect on reducing blood sugar and weighing down on our overall body weight more than a single GLP1 receptor agonist like Ozempic. Its enhanced signal is expected to guide to more effective treatment options for type 2 diabetes and maturity-related conditions.

    There are many clinical implications and differences for healthcare providers using Mounjaro or Ozempic for the patients. Compared to other options, Mounjaro is more likely to be better for someone with more extreme type 2 diabetes or obesity because it has higher efficacy when it comes to both lowering blood sugar and weight loss (Zheng et al., 2024). While Ozempic is generally better studied, it has a better safety and efficacy profile, which you may prefer over the GLP 1 receptor agonists in patients who do well with them or patients who require a more well-studied medication. Both drugs can cause gastrointestinal problems, but Mounjaro's dual activity might carry a very slightly higher chance of problems. Consequently, these medications will be compared, and finally, the choice will be made based on the patient's characteristics (response and tolerance to the possible side effects of treatment and the severity of the condition).

    Mounjaro and Ozempic are both efficacious, but both hold potential clinical complications. The risk of pancreatitis inflammation of the pancreas is one primary concern because GLP-1 receptor agonists have been associated with pancreatitis (Ayoub et al., 2025). Patients with pancreatitis background should be provided these drugs, and they should be closely monitored. In fact, another gastrointestinal symptom such nausea, vomiting, and diarrhea are very frequent, and some patients have more serious side effects that make difficult for patient to follow the treatment. Compared to Ozempic, Mounjaro's dual action might make stomach pain more likely.

    **References**

    **‌** Ayoub, M., Chela, H., Amin, N., Hunter, R., Anwar, J., Tahan, V., & Daglilar, E. (2025). Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis. _Journal of Clinical Medicine, 14_(3), 944. [https://doi.org/10.3390/jcm14030944](https://doi.org/10.3390/jcm14030944)

    Latif, W., Lambrinos, K. J., & Rodriguez, R. (2021). Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs). [https://www.ncbi.nlm.nih.gov/books/NBK572151/](https://www.ncbi.nlm.nih.gov/books/NBK572151/)

    Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024). Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. _Signal Transduction and Targeted Therapy, 9_(1), 234. [https://www.nature.com/articles/s41392-024-01931-z](https://www.nature.com/articles/s41392-024-01931-z)

    – 2 years ago

  • [Solved] discussion

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    **Hematopoietic:** J.D. is a 37 years old white woman who presents to her gynecologist complaining of a 2-month history of intermenstrual bleeding, menorrhagia, increased urinary frequency, mild incontinence, extreme fatigue, and weakness. Her menstrual period occurs every 28 days and lately there h…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    **Hematopoietic:**

    J.D. is a 37 years old white woman who presents to her gynecologist complaining of a 2-month history of intermenstrual bleeding, menorrhagia, increased urinary frequency, mild incontinence, extreme fatigue, and weakness. Her menstrual period occurs every 28 days and lately there have been 6 days of heavy flow and cramping. She denies abdominal distension, back-ache, and constipation. She has not had her usual energy levels since before her last pregnancy.

    **Past Medical History (PMH):**

    Upon reviewing her past medical history, the gynecologist notes that her patient is a G5P5with four pregnancies within four years, the last infant having been delivered vaginally four months ago. All five pregnancies were unremarkable and without delivery complications. All infants were born healthy. Patient history also reveals a 3-year history of osteoarthritis in the left knee, probably the result of sustaining significant trauma to her knee in an MVA when she was 9 years old. When asked what OTC medications she is currently taking for her pain and for how long she has been taking them, she reveals that she started taking ibuprofen, three tablets each day, about 2.5 years ago for her left knee. Due to a slowly progressive increase in pain and a loss of adequate relief with three tablets, she doubled the daily dose of ibuprofen. Upon the recommendation from her nurse practitioner and because long-term ibuprofen use can cause peptic ulcers, she began taking OTC omeprazole on a regular basis to prevent gastrointestinal bleeding. Patient history also reveals a 3-year history of HTN for which she is now being treated with a diuretic and a centrally acting antihypertensive drug. She has had no previous surgeries.

    **Case Study Questions**

    1. Name the contributing factors on J.D that might put her at risk to develop iron deficiency anemia.
    2. Within the case study, describe the reasons why J.D. might be presenting constipation and or dehydration.
    3. Why Vitamin B12 and folic acid are important on the erythropoiesis? What abnormalities their deficiency might cause on the red blood cells?
    4. The gynecologist is suspecting that J.D. might be experiencing iron deficiency anemia.

    In order to support the diagnosis, list and describe the clinical symptoms that J.D. might have positive for Iron deficiency anemia.
    5. If the patient is diagnosed with iron deficiency anemia, what do you expect to find as signs of this type of anemia? List and describe.
    6. Labs results came back for the patient. Hb 10.2 g/dL; Hct 30.8%; Ferritin 9 ng/dL; red blood cells are smaller and paler in color than normal. Research list and describe for appropriate recommendations and treatments for J.D.

    **Cardiovascular**

    Mr. W.G. is a 53-year-old white man who began to experience chest discomfort while playing tennis with a friend. At first, he attributed his discomfort to the heat and having had a large breakfast. Gradually, however, discomfort intensified to a crushing sensation in the sternal area and the pain seemed to spread upward into his neck and lower jaw. The nature of the pain did not seem to change with deep breathing. When Mr. G. complained of feeling nauseated and began rubbing his chest, his tennis partner was concerned that his friend was having a heart attack and called 911 on his cell phone. The patient was transported to the ED of the nearest hospital and arrived within 30 minutes of the onset of chest pain. In route to the hospital, the patient was placed on nasal cannula and an IV D5W was started. Mr. G. received aspirin (325 mg po) and 2 mg/IV morphine. He is allergic to meperidine (rash). His pain has eased slightly in the last 15 minutes but is still significant; was 9/10 in severity; now7/10. In the ED, chest pain was not relieved by 3 SL NTG tablets. He denies chills.

    **Case Study Questions**

    1. For patients at risk of developing coronary artery disease and patients diagnosed with acute myocardial infarct, describe the modifiable and non-modifiable risk factors.
    2. What would you expect to see on Mr. W.G. EKG and which findings described on the case are compatible with the acute coronary event?
    3. Having only the opportunity to choose one laboratory test to confirm the acute myocardial infarct, which would be the most specific laboratory test you would choose and why?
    4. How do you explain that Mr. W.G temperature has increased after his Myocardial Infarct, when that can be observed and for how long? Base your answer on the pathophysiology of the event.
    5. Explain to Mr. W.G. why he was experiencing pain during his Myocardial Infarct. Elaborate and support your answer.

    **Submission Instructions:**

    – Include both case studies in your post.
    – Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.

    Rubric

    **Discussion Rubric**

    Discussion Rubric

    CriteriaRatingsPts

    This criterion is linked to a Learning OutcomeIdentification of Main Issues, Problems, and Concepts

    **5** **to >4.0** **ptsDistinguished**

    **Identifies and demonstrates a sophisticated understanding of the issues, problems, and concepts.**

    **4** **to >3.0** **ptsExcellent**

    **Identifies and demonstrates an accomplished understanding of most issues, problems, and concepts.**

    **3** **to >0.0** **ptsFair**

    **Identifies and demonstrates an acceptable understanding of most issues, problems, and concepts.**

    **0** **ptsPoor**

    **Identifies and demonstrates an unacceptable understanding of most issues, problems, and concepts. Or nothing was posted.**

    5 pts

    This criterion is linked to a Learning OutcomeUse of Citations, Writing Mechanics and APA Formatting Guidelines

    **3** **ptsDistinguished**

    **Effectively uses the literature and other resources to inform their work. Exceptional use of citations and extended referencing. High level of APA precision and free of grammar and spelling errors.**

    **2** **ptsExcellent**

    **Effectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. Moderate level of APA precision and free of grammar and spelling errors.**

    **1** **ptsFair**

    **Ineffectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. APA style and writing mechanics need more precision and attention to detail.**

    **0** **ptsPoor**

    **Ineffectively uses the literature and other resources to inform their work. Unacceptable use of citations and extended referencing. APA style and writing mechanics need serious attention. Or nothing was posted.**

    3 pts

    This criterion is linked to a Learning OutcomeResponse to Posts of Peers

    **2** **ptsDistinguished**

    **Student constructively responded to two other posts and either extended, expanded or provided a rebuttal to each.**

    **1** **ptsFair**

    **Student constructively responded to one other post and either extended, expanded or provided a rebuttal.**

    **0** **ptsPoor**

    **Student provided no response to a peer's post.**

    2 pts

    Total Points: 1

    APA format

    references no less than 6 years old

    will be check through turn it in

    – 2 years ago

  • [Solved] weekly clinical experience 1

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    Describe your clinical experience for this week. – Did you face any challenges, any success? If so, what were they? – Describe the assessment of a patient, detailing the signs and symptoms (S&S), assessment, plan of care, and at least 3 possible differential diagnosis with rationales. – Mention the …

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Describe your clinical experience for this week.

    – Did you face any challenges, any success? If so, what were they?
    – Describe the assessment of a patient, detailing the signs and symptoms (S&S), assessment, plan of care, and at least 3 possible differential diagnosis with rationales.
    – Mention the health promotion intervention for this patient.
    – What did you learn from this week's clinical experience that can beneficial for you as an advanced practice nurse?
    – Support your plan of care with the current peer-reviewed research guideline.

    **Submission Instructions:**

    – Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources published within the last five years.

    – [\
    \
    ScreenShot2025-03-18at3.11.22PM.png](https://www.sweetstudy.com/files/screenshot2025-03-18at3-11-22pm-png "ScreenShot2025-03-18at3.11.22PM.png")

    – 2 years ago

  • [Solved] Pediatric Primary Care Foundation

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    You see a child whose family believes in natural therapy for illnesses (e.g., diet therapy, massage, heat treatments). How will you incorporate the family’s beliefs into the treatment of a child with an acute upper respiratory infection? With leukemia? **Submission Instructions:** – Your initial pos…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    You see a child whose family believes in natural therapy for illnesses (e.g., diet therapy, massage, heat treatments).

    How will you incorporate the family’s beliefs into the treatment of a child with an acute upper respiratory infection? With leukemia?

    **Submission Instructions:**

    – Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources published within the last five years.

    – 2 years ago

  • [Solved] Discussion Mounjaro vs Ozempic

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    Reply for the following discussion. at least 150 words, 2 references, APA style, Turnitin less than 10 % and 0% AI. New pharmacological treatments have been developed in response to the prevalence of obesity and type 2 diabetic mellitus (T2DM). Ozempic (semaglutide) and Mounjaro (tirzepatide) have b…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Reply for the following discussion. at least 150 words, 2 references, APA style, Turnitin less than 10 % and 0% AI.

    New pharmacological treatments have been developed in response to the prevalence of obesity and type 2 diabetic mellitus (T2DM). Ozempic (semaglutide) and Mounjaro (tirzepatide) have become important treatment choices among them. (Watanabe at el, 2024).

    An estimated $92 billion is spent on healthcare each year in the United States due to overweight and obesity, and adults who are obese have an additional $2505 in medical expenses annually, which are mostly related to morbidity and mortality from cardiovascular disease (CVD). Minorities are disproportionately affected by obesity, with non-Hispanic Black adults (34.9%) and Hispanic adults (44.8%) having the greatest rates.2. Obesity is made more complex from a health equity perspective since racial and ethnic minorities are linked to worse weight loss treatment response to behavioral, pharmaceutical, and surgical therapies.5. The FDA has approved several glucagon-like peptide 1 (GLP-1) receptor agonists that have been associated with significant weight loss, which has sparked interest in demand and cost estimates. (Person at el., 2023)

    Being glucagon-like peptide-1 receptor agonists (GLP-1 RAs), Mounjaro and Ozempic increase insulin secretion, postpone stomach emptying, and decrease hunger. Since tirzepatide (Mounjaro) is a dual agonist, it can potentially increase metabolic effects beyond those of semaglutide (Ozempic), which only targets GLP-1 receptors. It does this by targeting both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. (Watanabe at el, 2024)

    Tirzepatide may provide better results in weight loss and glycemic control than semaglutide, according to recent research. Patients on tirzepatide had a 1.8-fold higher chance of losing at least 5% of their body weight, a 2.5-fold higher chance of losing 10%, and a 3.2-fold higher chance of losing 15% of their body weight, according to cohort research conducted on individuals who were overweight or obese. Additionally, tirzepatide significantly increased the average reductions in body weight at 3, 6, and 12 months. (Rodriguez at el, 2024)

    Similarly, a randomized clinical trial reported that tirzepatide achieved greater reductions in hemoglobin A1c levels and body weight than semaglutide. The dual agonist activity of tirzepatide is hypothesized to contribute to these enhanced effects. (Frias at el, 20221)

    Common side effects of these drugs are mostly gastrointestinal in nature and include nausea, vomiting, and diarrhea. Between the two medications, the frequency of these adverse effects seems to be similar. Concerns have been raised recently, nevertheless, regarding possible severe side effects, such as eyesight issues linked to GLP-1 drugs like Ozempic and Mounjaro. There have been reports of non-arteritic anterior ischemic optic neuropathy (NAION), which causes abrupt blindness. Even though they are uncommon, these occurrences highlight the need for close observation.  (Watanabe at el, 2024)

    For individuals with type 2 diabetes and obesity, tirzepatide's improved effectiveness in weight loss and glycemic management presents a potential alternative. However, when choosing a treatment, factors like cost, patient comorbidities, and possible side effects are very important. For optimal therapy customization, healthcare providers must consider these aspects. The long-term safety characteristics of these drugs must be thoroughly clarified by ongoing research and post-marketing surveillance. (Frias at el, 2021)

    The pharmaceutical treatment of type 2 diabetes and obesity has benefited greatly by the development of Mounjaro (tirzepatide) and Ozempic (semaglutide). Despite tirzepatide's increased effectiveness in recent research, clinical judgments must be based on the unique characteristics of each patient as well as any possible hazards. To maximize therapeutic approaches and guarantee patient safety, more research is necessary. (ADA, 2021)

    – 2 years ago

  • [Solved] Diff RN roles

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    Compare the primary care NP role with other APN roles. What are the similarities among the roles, what are the differences, and how would you communicate the role to a healthcare provider and a consumer? **Submission Instructions:** – Your initial post should be at least 500 words, formatted and cit…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Compare the primary care NP role with other APN roles. What are the similarities among the roles, what are the differences, and how would you communicate the role to a healthcare provider and a consumer?

    **Submission Instructions:**

    – Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.

    References not older than 6 years

    i will have to submit it to turn it in

    no chat gbt

    rubric

    **Discussion Rubric**

    Discussion Rubric

    CriteriaRatingsPts

    This criterion is linked to a Learning OutcomeIdentification of Main Issues, Problems, and Concepts

    **5** **ptsDistinguished**

    **Identify and demonstrate a sophisticated understanding of the issues, problems, and concepts.**

    **4** **ptsExcellent**

    **Identifies and demonstrate an accomplished understanding of most of issues, problems, and concepts.**

    **2** **ptsFair**

    **Identifies and demonstrate an an acceptable understanding of most of issues, problems, and concepts.**

    **1** **ptsPoor**

    **Identifies and demonstrate an unacceptable understanding of most of issues, problems, and concepts.**

    5 pts

    This criterion is linked to a Learning OutcomeUse of Citations, Writing Mechanics and APA Formatting Guidelines

    **3** **ptsDistinguished**

    **Effectively uses the literature and other resources to inform their work. Exceptional use of citations and extended referencing. High level of APA precision and free of grammar and spelling errors.**

    **2** **ptsExcellent**

    **Effectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. Moderate level of APA precision and free of grammar and spelling errors.**

    **1** **ptsFair**

    **Ineffectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. APA style and writing mechanics need more precision and attention to detail.**

    **0** **ptsPoor**

    **Ineffectively uses the literature and other resources to inform their work. An unacceptable use of citations and extended referencing. APA style and writing mechanics need serious attention.**

    3 pts

    This criterion is linked to a Learning OutcomeResponse to Posts of Peers

    **2** **ptsDistinguished**

    **Student constructively responded to two other posts and either extended, expanded or provided a rebuttal to each.**

    **1** **ptsFair**

    **Student constructively responded to one other post and either extended, expanded or provided a rebuttal.**

    **0** **ptsPoor**

    **Student provided no response to a peer's post.**

    2 pts

    Total Points: 10

    – 2 years ago

  • [Solved] Consider what history would be necessary to collect from this patient.

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering Consider what history would be necessary to collect from this patient..

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.